Investigators concluded, "This prospective study provides further evidence for the effects of medical cannabis on chronic pain and related symptoms."
Authors reported, "This study demonstrates that the sublingual 20 mg CBD tablet should be considered as a safe and effective treatment for pDPN."
Researchers concluded: "[T]he liberalization of cannabis laws does not disrupt gains made through the implementation of tobacco control policies."
Among those patients who reported using opioids at baseline, 93 percent either "decreased or stopped [using] opioids following cannabis initiation."
Authors reported: "[T]his is the first case report of a patient suffering from impairing and treatment-resistant stuttering, who markedly improved after treatment with medicinal cannabis."
“Our results suggest that young adults who lived in an area with a greater density of any type of outlet were not significantly more likely to report stronger intentions to use cannabis.”
Authors concluded, “These preliminary single-center data showing no increased rates of cannabis use in patients with trauma after legalization are reassuring.”
Researchers also reported that cannabis-consuming subjects achieved better on measurements of cognitive performance.